SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-107137
Filing Date
2015-03-26
Accepted
2015-03-26 17:01:15
Documents
18
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d892830d20f.htm 20-F 1615487
2 EX-12.1 d892830dex121.htm EX-12.1 6038
3 EX-12.2 d892830dex122.htm EX-12.2 5938
4 EX-13.1 d892830dex131.htm EX-13.1 3839
5 GRAPHIC g892830img152a.jpg GRAPHIC 4591
6 GRAPHIC g892830img63.jpg GRAPHIC 19619
7 GRAPHIC g892830img64a.jpg GRAPHIC 4186
8 GRAPHIC g892830img64c.jpg GRAPHIC 3898
9 GRAPHIC g892830img65a.jpg GRAPHIC 4304
10 GRAPHIC g892830img65b.jpg GRAPHIC 4474
11 GRAPHIC g892830img69.jpg GRAPHIC 31608
12 GRAPHIC g892830img72.jpg GRAPHIC 11392
13 GRAPHIC g892830img76a.jpg GRAPHIC 19883
14 GRAPHIC g892830img76b.jpg GRAPHIC 20415
15 GRAPHIC g892830img77a.jpg GRAPHIC 14549
16 GRAPHIC g892830img77b.jpg GRAPHIC 15263
17 GRAPHIC g892830img79.jpg GRAPHIC 16419
18 GRAPHIC g892830img83.jpg GRAPHIC 13076
  Complete submission text file 0001193125-15-107137.txt   1887439
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36815 | Film No.: 15728373
SIC: 2834 Pharmaceutical Preparations